Cargando...

Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib

In normal cell cycle progression, transition of G0/G1 phase to synthesis (S) phase for breast and other cells is regulated by association of cyclin D and cyclin-dependent kinases 4 and 6 (CDK4/6) that leads to phosphorylation of retinoblastoma (Rb) protein. Imbalance of this cyclin D-CDK4/6-inhibito...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer (Dove Med Press)
Autores principales: Edessa, Dumessa, Sisay, Mekonnen
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5726365/
https://ncbi.nlm.nih.gov/pubmed/29263697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S150540
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!